Bristol-Myers Squibb
BMY
#190
Rank
HK$875.55 B
Marketcap
HK$430.09
Share price
1.42%
Change (1 day)
-4.14%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2025 (TTM): HK$23.15

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is HK$23.20. In 2024 the company made an earnings per share (EPS) of -HK$34.53 a decrease over its 2023 EPS that were of HK$30.31.

EPS history for Bristol-Myers Squibb from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$23.15-167.05%
2024-HK$34.53-213.92%
2023HK$30.3130.2%
2022HK$23.28-6.04%
2021HK$24.78-179.29%
2020-HK$31.25-281.37%
2019HK$17.23-27.21%
2018HK$23.67
2016HK$20.86175.26%
2015HK$7.58-19.83%
2014HK$9.45-22.44%
2013HK$12.1934.48%
2012HK$9.06

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$81.56 251.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$57.50 147.81%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$13.44-42.09%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$10.56-54.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$160.30 590.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$101.80 338.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$28.95 24.77%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
HK$85.86 270.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$59.33 155.68%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$23.71 2.19%๐Ÿ‡ฌ๐Ÿ‡ง UK